TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: POST-APPROVAL STUDY of TRANSCAROTID ARTERY REVASCULARIZATION in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE. The ROADSTER 2 Study.
Brief Summary: The ROADSTER 2 Study is intended to evaluate real world usage of the ENROUTE Transcarotid Stent when used with the ENROUTE Transcarotid Neuroprotection System by physicians of varying experience with the transcarotid technique.


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Device: Carotid artery stenting with filter (interventional) | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Carotid artery endarterectomy (surgical) | Intervention Type: DEVICE; Name: Carotid artery stenting with filter (interventional); Assigned to Arm(s): 1 | Intervention Type: PROCEDURE; Name: Carotid artery endarterectomy (surgical); Assigned to Arm(s): 2
B: Intervention Type: DEVICE; Name: Cordis Nitinol Stent; Assigned to Arm(s): N/A | Intervention Type: DEVICE; Name: PRECISE tapered stent; Assigned to Arm(s): N/A | Intervention Type: DEVICE; Name: ANGIOGUARD XP Emboli Capture Guidewire (ECGW); Assigned to Arm(s): N/A
C: N/A
D: Arm Label: Carotid Artery Endarterectomy (CEA); Type: ACTIVE_COMPARATOR; Interventions: Procedure: Carotid Endarterectomy (CEA) | Arm Label: Carotid Artery Stenting (CAS); Type: ACTIVE_COMPARATOR; Interventions: Device: Carotid Artery Stenting (CAS) | Intervention Type: PROCEDURE; Name: Carotid Endarterectomy (CEA); Assigned to Arm(s): Carotid Artery Endarterectomy (CEA) | Intervention Type: DEVICE; Name: Carotid Artery Stenting (CAS); Assigned to Arm(s): Carotid Artery Stenting (CAS)

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Tolerability to a New Free Amino Acid-based Formula in Children With Cow's Milk Protein Allergy
Brief Summary: It is a study to assess the tolerance to a new commercially available infant formula in children affected by Cow's Milk Allergy.


Options:
A: Arm Label: Amix; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Amix | Intervention Type: DIETARY_SUPPLEMENT; Name: Amix; Assigned to Arm(s): Amix
B: Arm Label: New Neocate; Type: EXPERIMENTAL; Interventions: Dietary Supplement: new Neocate | Arm Label: Neocate Infant; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Neocate Infant | Intervention Type: DIETARY_SUPPLEMENT; Name: Neocate Infant; Assigned to Arm(s): Neocate Infant | Intervention Type: DIETARY_SUPPLEMENT; Name: new Neocate; Assigned to Arm(s): New Neocate
C: Arm Label: Standard infant formula; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Standard infant formula | Arm Label: Protein-reduced whey formula; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Protein-reduced whey formula | Arm Label: Protein-reduced α-lactalbumin formula; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Protein-reduced α-lactalbumin formula | Arm Label: Breast-feeding; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DIETARY_SUPPLEMENT; Name: Protein-reduced α-lactalbumin formula; Assigned to Arm(s): Protein-reduced α-lactalbumin formula | Intervention Type: DIETARY_SUPPLEMENT; Name: Protein-reduced whey formula; Assigned to Arm(s): Protein-reduced whey formula | Intervention Type: DIETARY_SUPPLEMENT; Name: Standard infant formula; Assigned to Arm(s): Standard infant formula
D: Arm Label: Experimental Infant Formula; Type: EXPERIMENTAL; Interventions: Other: Experimental Infant Formula | Intervention Type: OTHER; Name: Experimental Infant Formula; Assigned to Arm(s): Experimental Infant Formula

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Multicentre, Cross-over, PRAgmatic Trial in Atopic Dermatitis Testing Long-term Control Effectiveness of New Phototherapy Regimen During Winter as an add-on Therapy, Coupled With Oral Vitamin D Supplementation vs. Placebo in a Randomised, Parallel-group Trial
Brief Summary: Spaced phototherapy sessions during winter as add-on therapy in combination with vitamin D supplementation or not, could be beneficial to improve disease LTC in AD patients


Options:
A: Arm Label: Domestic ion-exchange water softener; Type: EXPERIMENTAL; Interventions: Device: Domestic ion-exchange water softener | Arm Label: Usual hard water supply; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Domestic ion-exchange water softener; Assigned to Arm(s): Domestic ion-exchange water softener
B: Arm Label: Cholecalciferol; Type: ACTIVE_COMPARATOR; Interventions: Drug: Cholecalciferol | Arm Label: Placebo of cholecalciferol; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo of cholecalciferol | Intervention Type: DRUG; Name: Cholecalciferol; Assigned to Arm(s): Cholecalciferol | Intervention Type: DRUG; Name: Placebo of cholecalciferol; Assigned to Arm(s): Placebo of cholecalciferol
C: Arm Label: Prevalent case of atopic dermatitis; Type: N/A; Interventions: Other: No intervention | Arm Label: Controls; Type: N/A; Interventions: Other: No intervention | Intervention Type: OTHER; Name: No intervention; Assigned to Arm(s): Controls, Prevalent case of atopic dermatitis
D: Arm Label: A: UVA1; Type: EXPERIMENTAL; Interventions: Procedure: UVA1 phototherapy | Arm Label: B: NB UVB; Type: EXPERIMENTAL; Interventions: Procedure: NB-UVB phototherapy | Intervention Type: PROCEDURE; Name: UVA1 phototherapy; Assigned to Arm(s): A: UVA1 | Intervention Type: PROCEDURE; Name: NB-UVB phototherapy; Assigned to Arm(s): B: NB UVB

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effects of Dual Task Training on Motor and Non-Motor Function in Individuals With Parkinson's Disease
Brief Summary: The primary aim of the proposed project is to characterize dual tasking (DT) deficits to improve motor, cognitive, and quality of life outcomes in individuals with Parkinson's disease (PD). Phase 1 of the intervention will involve an in-depth gait analysis on 15 individuals with PD. This gait analysis will utilize the Computer Assisted Rehabilitation Environment (CAREN) system, a virtual reality system with a fully integrated 3-D motion capture system. The purpose of Phase 1 is to generalize characteristics of gait and postural control during specific DT conditions. Phase 2 (N=20) involves the clinical translation of these findings. This phase will involve creating a clinical intervention based on the objective information gathered the CAREN system. The intervention will take place 3x/week for a total of 8 weeks. Interventional groups will include: 1) DT clinical group (N=10) and 2) Single task group (N=10). Outcome measures will be used at the beginning and end of the intervention to assess the feasibility and efficacy of the intervention.


Options:
A: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Azilect®; Type: EXPERIMENTAL; Interventions: Drug: Azilect® | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Azilect®; Assigned to Arm(s): Azilect®
B: Arm Label: Dual Task Group; Type: EXPERIMENTAL; Interventions: Behavioral: Dual Task Group | Arm Label: Single Task Group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Single Task Group | Intervention Type: BEHAVIORAL; Name: Dual Task Group; Assigned to Arm(s): Dual Task Group | Intervention Type: BEHAVIORAL; Name: Single Task Group; Assigned to Arm(s): Single Task Group
C: Arm Label: IPX066; Type: EXPERIMENTAL; Interventions: Drug: IPX066, Drug: IR CD-LD | Arm Label: IR CD-LD; Type: ACTIVE_COMPARATOR; Interventions: Drug: IPX066, Drug: IR CD-LD | Intervention Type: DRUG; Name: IPX066; Assigned to Arm(s): IPX066, IR CD-LD | Intervention Type: DRUG; Name: IR CD-LD; Assigned to Arm(s): IPX066, IR CD-LD
D: Arm Label: TT+VR; Type: EXPERIMENTAL; Interventions: Other: TT+VR | Arm Label: TT alone; Type: ACTIVE_COMPARATOR; Interventions: Other: TT alone | Intervention Type: OTHER; Name: TT+VR; Assigned to Arm(s): TT+VR | Intervention Type: OTHER; Name: TT alone; Assigned to Arm(s): TT alone

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Efficacy and Safety of MgSO4 as Tocolytics Compared to Ritodrine in Preterm Labor
Brief Summary: Ritodrine is the conventional and the only approved tocolytics in Korea(by KFDA), although it was withdrawn from the US market more than 10 years ago. As already known well, ritodrine has many side effects such as tachycardia, hyperglycemia, pulmonary edema and so on. When such complications of ritodrine appears, clinicians consider of using MgSO4 as substitute, but its use is off-the-label yet in Korea. Facing this discrepancy, the investigators want to compare the efficacy and safety of MgSO4 with ritodrine and prove that MgSO4 is not inferior to ritodrine as tocolytics. For the singleton and twin pregnancies between 24+0weeks and 34 completed weeks whose uterine contraction is more than 4 during 20 minutes period with their cervical ripening is more than 25%, the investigators randomise them in Ritodrine group or MgSO4 group. Then, the investigators will check the change of their interval of uterine contraction, degree of pain and the appearance of any side effects or treatment failure sign.


Options:
A: Arm Label: YTP(ritodrine) arm; Type: ACTIVE_COMPARATOR; Interventions: Drug: YTP(Ritodrine) | Arm Label: MgSO4 arm; Type: EXPERIMENTAL; Interventions: Drug: MgSO4 | Intervention Type: DRUG; Name: MgSO4; Assigned to Arm(s): MgSO4 arm | Intervention Type: DRUG; Name: YTP(Ritodrine); Assigned to Arm(s): YTP(ritodrine) arm
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Nifedlipine | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Magnesium | Intervention Type: DRUG; Name: Magnesium; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: Nifedlipine; Assigned to Arm(s): 1
C: Arm Label: Magnesium sulfate; Type: ACTIVE_COMPARATOR; Interventions: Drug: Magnesium sulfate | Arm Label: Normal saline; Type: PLACEBO_COMPARATOR; Interventions: Drug: Magnesium sulfate | Intervention Type: DRUG; Name: Magnesium sulfate; Assigned to Arm(s): Magnesium sulfate, Normal saline
D: Arm Label: Nifedipine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Nifedipine 20 Mg | Arm Label: Ritodrine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Ritodrine Oral Tablet | Intervention Type: DRUG; Name: Nifedipine 20 Mg; Assigned to Arm(s): Nifedipine | Intervention Type: DRUG; Name: Ritodrine Oral Tablet; Assigned to Arm(s): Ritodrine

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Low InTensity Exercise Intervention in PAD
Brief Summary: This proposed study will determine whether a home-based exercise intervention that avoids continuous supervision and exercise-related ischemic pain improves walking performance at 52-week follow-up in people with PAD, compared to an attention control group and compared to a high intensity exercise intervention. In our secondary aims, we will determine whether high intensity exercise improves six-minute walk distance as compared to the attention control group. In secondary aims, we will also determine whether low intensity exercise and high intensity home-based exercise, respectively, improve patient reported outcomes, physical activity, and treadmill walking performance compared to attention control. Our intervention directly addresses two aspects of current practice guidelines that are major barriers to exercise for patients with PAD: 1) the recommendation for supervised exercise and 2) the recommendation for high intensity ischemic-pain inducing walking exercise.


Options:
A: Arm Label: Mobilyze!; Type: EXPERIMENTAL; Interventions: Behavioral: Mobilyze! | Intervention Type: BEHAVIORAL; Name: Mobilyze!; Assigned to Arm(s): Mobilyze!
B: Arm Label: Group 1; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise | Arm Label: Group 2; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise | Arm Label: Group 3; Type: ACTIVE_COMPARATOR; Interventions: Other: Attention control | Intervention Type: BEHAVIORAL; Name: Exercise; Assigned to Arm(s): Group 1, Group 2 | Intervention Type: OTHER; Name: Attention control; Assigned to Arm(s): Group 3
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Walking Exercise | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: Walking Exercise | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Control--Resistance Training | Intervention Type: BEHAVIORAL; Name: Walking Exercise; Assigned to Arm(s): 1, 2 | Intervention Type: BEHAVIORAL; Name: Control--Resistance Training; Assigned to Arm(s): 3
D: Arm Label: WalkingPad plus Psychological Intervention - PsyWPad Group; Type: EXPERIMENTAL; Interventions: Behavioral: WalkingPad plus Psychological Intervention - PsyWPad Group | Arm Label: WalkingPad plus Virtual Assistant - CyberWPad Group; Type: EXPERIMENTAL; Interventions: Behavioral: WalkingPad plus Virtual Assistant - CyberWPad Group | Arm Label: Paper WalkingPad group - PaperWPad Group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: WalkingPad group - Paper WPad Group | Intervention Type: BEHAVIORAL; Name: WalkingPad plus Psychological Intervention - PsyWPad Group; Assigned to Arm(s): WalkingPad plus Psychological Intervention - PsyWPad Group | Intervention Type: BEHAVIORAL; Name: WalkingPad plus Virtual Assistant - CyberWPad Group; Assigned to Arm(s): WalkingPad plus Virtual Assistant - CyberWPad Group | Intervention Type: BEHAVIORAL; Name: WalkingPad group - Paper WPad Group; Assigned to Arm(s): Paper WalkingPad group - PaperWPad Group

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Fostering Resilience: An Intervention for Women Physicians at Risk for Burnout
Brief Summary: Physicians in general are at risk for burnout, and this risk is heightened among women, particularly mothers. In a randomized design, central hypotheses in this study are that mothers who attend our 12-week Relational Psychotherapy Mothers Group (RPMG) intervention will show significantly greater decreases in stress, depression, burnout, and associated risk biomarker indices, as compared to comparison controls (who would meet in unstructured gatherings, for an hour a week for 12 weeks). Additionally the investigators hypothesize that the gains would be maintained three months after the intervention is completed.


Options:
A: Arm Label: Electronic intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Electronic intervention suggesting behavioral activity | Arm Label: control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Electronic intervention suggesting behavioral activity; Assigned to Arm(s): Electronic intervention
B: Arm Label: Immediate Coaching Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Professional Coaching | Arm Label: Control/Delayed Coaching Intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Professional Coaching | Intervention Type: BEHAVIORAL; Name: Professional Coaching; Assigned to Arm(s): Control/Delayed Coaching Intervention, Immediate Coaching Intervention
C: Arm Label: Group therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Manualized Therapy | Arm Label: Control Group; Type: OTHER; Interventions: Behavioral: Control Group | Intervention Type: BEHAVIORAL; Name: Manualized Therapy; Assigned to Arm(s): Group therapy | Intervention Type: BEHAVIORAL; Name: Control Group; Assigned to Arm(s): Control Group
D: Arm Label: 2 weeks; Type: ACTIVE_COMPARATOR; Interventions: Other: 2-week rotation | Arm Label: 4 weeks; Type: PLACEBO_COMPARATOR; Interventions: Other: 4-week rotation | Intervention Type: OTHER; Name: 2-week rotation; Assigned to Arm(s): 2 weeks | Intervention Type: OTHER; Name: 4-week rotation; Assigned to Arm(s): 4 weeks

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Fostering Resilience: An Intervention for Women Physicians at Risk for Burnout
Brief Summary: Physicians in general are at risk for burnout, and this risk is heightened among women, particularly mothers. In a randomized design, central hypotheses in this study are that mothers who attend our 12-week Relational Psychotherapy Mothers Group (RPMG) intervention will show significantly greater decreases in stress, depression, burnout, and associated risk biomarker indices, as compared to comparison controls (who would meet in unstructured gatherings, for an hour a week for 12 weeks). Additionally the investigators hypothesize that the gains would be maintained three months after the intervention is completed.


Options:
A: Arm Label: Intervention Group; Type: EXPERIMENTAL; Interventions: Behavioral: ACTr (Acceptance and Commitment Training) | Arm Label: Wait-list control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: ACTr (Acceptance and Commitment Training); Assigned to Arm(s): Intervention Group
B: Arm Label: Mindfulness-based self-care; Type: EXPERIMENTAL; Interventions: Behavioral: Mindfulness-based self care | Arm Label: Life as usual control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Mindfulness-based self care; Assigned to Arm(s): Mindfulness-based self-care
C: Arm Label: Follow up; Type: EXPERIMENTAL; Interventions: Behavioral: Follow up | Arm Label: Usual Treatment; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Follow up; Assigned to Arm(s): Follow up
D: Arm Label: Group therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Manualized Therapy | Arm Label: Control Group; Type: OTHER; Interventions: Behavioral: Control Group | Intervention Type: BEHAVIORAL; Name: Manualized Therapy; Assigned to Arm(s): Group therapy | Intervention Type: BEHAVIORAL; Name: Control Group; Assigned to Arm(s): Control Group

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Fostering Resilience: An Intervention for Women Physicians at Risk for Burnout
Brief Summary: Physicians in general are at risk for burnout, and this risk is heightened among women, particularly mothers. In a randomized design, central hypotheses in this study are that mothers who attend our 12-week Relational Psychotherapy Mothers Group (RPMG) intervention will show significantly greater decreases in stress, depression, burnout, and associated risk biomarker indices, as compared to comparison controls (who would meet in unstructured gatherings, for an hour a week for 12 weeks). Additionally the investigators hypothesize that the gains would be maintained three months after the intervention is completed.


Options:
A: Arm Label: Intervention Group; Type: OTHER; Interventions: Behavioral: Internet-Based Mindfulness Program - Stress Free Now for Healers | Arm Label: Active Control Group; Type: OTHER; Interventions: Behavioral: Active Control Group - Relaxing Music | Intervention Type: BEHAVIORAL; Name: Internet-Based Mindfulness Program - Stress Free Now for Healers; Assigned to Arm(s): Intervention Group | Intervention Type: BEHAVIORAL; Name: Active Control Group - Relaxing Music; Assigned to Arm(s): Active Control Group
B: Arm Label: Group therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Manualized Therapy | Arm Label: Control Group; Type: OTHER; Interventions: Behavioral: Control Group | Intervention Type: BEHAVIORAL; Name: Manualized Therapy; Assigned to Arm(s): Group therapy | Intervention Type: BEHAVIORAL; Name: Control Group; Assigned to Arm(s): Control Group
C: Arm Label: Active ABMT8; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Active ABMT8 | Arm Label: Active ABMT4; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Active ABMT4 | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Placebo | Intervention Type: BEHAVIORAL; Name: Active ABMT8; Assigned to Arm(s): Active ABMT8 | Intervention Type: BEHAVIORAL; Name: Active ABMT4; Assigned to Arm(s): Active ABMT4 | Intervention Type: BEHAVIORAL; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Mindfulness-Based Resilience Training; Type: EXPERIMENTAL; Interventions: Behavioral: Mindfulness-Based Resilience Training | Arm Label: Stress Management Education; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Stress Management Education | Arm Label: No Intervention Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Mindfulness-Based Resilience Training; Assigned to Arm(s): Mindfulness-Based Resilience Training | Intervention Type: BEHAVIORAL; Name: Stress Management Education; Assigned to Arm(s): Stress Management Education

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Transobturator Sling Compared With Single-incision Mini-sling for the Treatment of Stress Urinary Incontinence: A Randomized Controlled Trial
Brief Summary: 1. OBJECTIVE:

   To determine the efficacy and safety of a single-incision mini-sling compared with a transobturator midurethral sling for stress urinary incontinence (SUI) treatment.
2. METHODS:

This prospective single-center randomized controlled trial will involve 100 women with a diagnosis of SUI. Primary outcomes were the objective and subjective cure rates, defined as negative cough stress and pad tests, and satisfaction rates. Quality of life assessed by the Incontinence Quality of Life Questionnaire and the Urogenital Distress Inventory Short Form, operation time, complications, and reoperation rates were also recorded. The efficacy was analyzed using a noninferiority test with a margin of 15%. For the noninferiority test, a P value \>.05 rejects the noninferiority hypothesis of the mini-sling.


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Device: tension-free vaginal tape | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Device: TVT-SECUR device | Intervention Type: DEVICE; Name: tension-free vaginal tape; Assigned to Arm(s): 1 | Intervention Type: DEVICE; Name: TVT-SECUR device; Assigned to Arm(s): 2
B: Arm Label: Ajust sling; Type: EXPERIMENTAL; Interventions: Procedure: Ajust system, Procedure: TVT/TVT-O | Arm Label: TVT/TVT-O, polypropylne slings; Type: EXPERIMENTAL; Interventions: Procedure: Ajust system, Procedure: TVT/TVT-O | Intervention Type: PROCEDURE; Name: Ajust system; Assigned to Arm(s): Ajust sling, TVT/TVT-O, polypropylne slings | Intervention Type: PROCEDURE; Name: TVT/TVT-O; Assigned to Arm(s): Ajust sling, TVT/TVT-O, polypropylne slings
C: Arm Label: Single incision mini-sling; Type: EXPERIMENTAL; Interventions: Device: Ophira | Arm Label: Transobturator sling; Type: ACTIVE_COMPARATOR; Interventions: Device: Transobturator sling | Intervention Type: DEVICE; Name: Ophira; Assigned to Arm(s): Single incision mini-sling | Intervention Type: DEVICE; Name: Transobturator sling; Assigned to Arm(s): Transobturator sling
D: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Ajust positioning | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: MiniArc positioning | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Procedure: TVT secur system positioning | Arm Label: 4; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Tension free vaginal ttape | Intervention Type: PROCEDURE; Name: MiniArc positioning; Assigned to Arm(s): 2 | Intervention Type: PROCEDURE; Name: TVT secur system positioning; Assigned to Arm(s): 3 | Intervention Type: PROCEDURE; Name: Ajust positioning; Assigned to Arm(s): 1 | Intervention Type: PROCEDURE; Name: Tension free vaginal ttape; Assigned to Arm(s): 4

Answer: C